News (95)

Update
DateNews
Jun 12, 2017Business Wire - Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital
May 2, 2017Business Wire - Concert Pharmaceuticals Reports First Quarter 2017 Financial Results
Mar 10, 2017Xconomy - Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More
Mar 6, 2017Business Wire - Concert Pharmaceuticals Reports Year Ended 2016 Financial Results
Mar 6, 2017Business Wire - Vertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis
Mar 2, 2017Business Wire - Concert Pharmaceuticals to Report Full Year 2016 Results on March 6, 2017, and Present at Upcoming Investor Conferences
Dec 21, 2016Xconomy - 14 For ’17: Key Clinical Data to Watch For Next Year (Part 1)
Nov 8, 2016Business Wire - Concert Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Company Update
Nov 3, 2016PRNewswire All - PDE Inhibitors Market, 2026: Approx 40 PDE Inhibitors Currently in Various Stages of Clinical/Preclinical Development - Research and Markets
Sep 18, 2016Haaretz - Business in Brief: Zadik Bino Gives Up Control of Paz in Share Sale
Sep 1, 2016Business Wire - Concert Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 9, 2016ir.concertpharma.com - About Concert
Aug 9, 2016Business Wire - Concert Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Company Update
Aug 2, 2016Business Wire - Concert Pharmaceuticals to Report Second Quarter 2016 Financial Results on August 9, 2016
Jul 8, 2016Business Wire - PureTech Appoints Feng Zhang to Scientific Advisory Board and Expands Team and Advisory Group
Jul 6, 2016Business Wire - Concert Pharmaceuticals Announces Webcast at Cantor Fitzgerald Healthcare Conference
May 17, 2016Business Wire - Concert Pharmaceuticals to Present at Several Upcoming Investor Conferences
May 5, 2016Business Wire - Concert Pharmaceuticals Reports First Quarter 2016 Financial Results
Mar 23, 2016Business Wire - Concert Pharmaceuticals Names Meghan FitzGerald to its Board of Directors
Mar 3, 2016Xconomy - Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer